Bayer lack of initiative
2023.01.22 08:09
Bayer lack of initiative
By Ray Johnson
Budrigannews.com – Bayer (OTC) According to an interview published in WirtschaftsWoche, investor Union Investment criticized Bayer’s chair for a lack of engagement, such as considering a spin-off of the company’s consumer health division.
Bluebell Capital Partners, an activist investor, wants Bayer to break up with a sale of its consumer health unit and a later separation of the company’s pharmaceuticals and agriculture businesses.
Markus Manns, a portfolio manager at Union Investment, disclosed to WirtschaftsWoche that Bayer Chair Norbert Winkeljohann “does seek dialogue with investors, but he should have initiated more.”
Manns went on to say, “It would certainly have been a matter for the supervisory board to help initiate a spin-off of Consumer Health.” He mentioned that chairs at rival businesses are significantly more involved in generating value for shareholders.
Bayer’s spokesperson declined to discuss Union Investment’s position. However, in general, the spokesperson stated, “We are always open to a constructive dialogue with our stakeholders.”
